Regenosca
PrivateLast Round
Pre Seed
Jul 22, 2024
Total Funding Raised
$1.29M
Company Overview
Regenosca is a biotechnology company that creates innovative bio-implants that enable the body to attract and organize its own cells for seamless tissue healing.
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Regenosca Comps
Public and private peers based on sector, stage, and business model.
Regenosca Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Jul 22, 2024 | ||||
| Grant | Nov 27, 2020 |
Key People
Founding team and executive leadership
Regenosca Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Business Angels Switzerland | Pre Seed |
| Venture Kick | Pre Seed, Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 22, 2024
Raised $1.12M from Business Angels Switzerland and Venture Kick.
- Nov 27, 2020
$165K grant received from Venture Kick.
Regenosca Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Regenosca's valuation, stock price, and market status.
